Noetic Fund invests in early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies.
Noetic Fund is a venture fund launched by Grey House Partners GP Inc. to invest in emerging and early-stage wellness, therapeutic and pharmaceutical companies around the globe. The company has proudly taken the North Star pledge and believes in the importance of stewarding this sector in the right way. It aims to nurture the scientific advancement of mental, emotional, psychological and physical health by investing in alternative therapies, modalities, and sciences that are committed to optimizing our human experience.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 6, 2021
Gilgamesh Pharmaceuticals
|
Series A | $27M | Biotechnology | — |